WORLD CLASS HEALTHCARE SOLUTIONS
Call: 080-40987695,96,97
Contact Us
shadow

Cardiac & Anti-Diabetic

Home »  Products » Cardiac & Anti-Diabetic  » REVOSART-A TABLETS
pro-details

REVOSART-A 

Telmisartan IP 40 mg + Amlodipine Besilate IP 5 mg Tablets

 

INDICATIONS

Hypertension

Heart stroke

Kidney Problems

Heart Failure

 

This combination works by direct AT-1 receptor blockade and calcium ions inhibition across cell membrances.

Enlisted as one of the effective choices for the first line treatment in hypertension.

Excellent combination regimen for those with co-morbidities like diabetes mellitus,heart strokes,heart failure and kidney problems.

Low -dose combination therapy that appears a better therapeutic approach than high-dose mono-therapy.

SBP target achieved in 80% cases of group-A(high dose mono-therapy of Telmisartan 80mg) and 90.323% cases of group C-(Telmisartan 40mg and Amlodipine 5 mg)

Trials suggest that Telmisartan & Amlodipine combination in hypertensive have profound complimentary action.

Replacement of Valsartan by Telmisartan in Amlodipine -treated hypertensive patients shows a significant reduction in both mean systolic BP & diastolic BP.

143.7/82.3 mm Hg at baseline to 135.4/77.5mmHg after the Telmisartan treatment.

Additional BP lowering can be achieved by switching to 5 mg Amlodipine plus 40mg Telmisartan from 5mg Amlodipine plus 8 mg Candesartan.